NFKB1 and chronic obstructive pulmonary disease: Collectively, our results confirm that luteolin can alleviate inflammation and oxidative stress in COPD via NOX4‐mediated NF‐κB signaling inhibition, which provides a theoretical basis for the application of luteolin in the treatment of COPD.